{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:52:07Z","timestamp":1789084327137,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470829"],"award-info":[{"award-number":["82470829"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-026-01697-7","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:47:30Z","timestamp":1775645250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A clinical study on the effects of teriparatide and denosumab on bone metabolism and gut microbiota in osteoporotic fracture patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Jie","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9042-8523","authenticated-orcid":false,"given":"Limin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"1697_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/jama.2025.6003","volume":"334","author":"SN Morin","year":"2025","unstructured":"Morin SN, Leslie WD, Schousboe JT (2025) Osteoporosis: a review. JAMA 334:894\u2013907. https:\/\/doi.org\/10.1001\/jama.2025.6003","journal-title":"JAMA"},{"key":"1697_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(25)01385-6","author":"C Ye","year":"2025","unstructured":"Ye C, Ebeling P, Kline G (2025) Osteoporosis. Lancet. https:\/\/doi.org\/10.1016\/s0140-6736(25)01385-6","journal-title":"Lancet"},{"key":"1697_CR3","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s00198-015-3154-6","volume":"26","author":"A Od\u00e9n","year":"2015","unstructured":"Od\u00e9n A, McCloskey EV, Kanis JA et al (2015) Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int 26:2243\u20132248. https:\/\/doi.org\/10.1007\/s00198-015-3154-6","journal-title":"Osteoporos Int"},{"key":"1697_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2025.100707","volume":"6","author":"A Nguyen","year":"2025","unstructured":"Nguyen A, Lee P, Rodriguez EK et al (2025) Addressing the growing burden of musculoskeletal diseases in the ageing US population: challenges and innovations. Lancet Healthy Longev 6:100707.10.1016\/j.lanhl.2025.100707","journal-title":"Lancet Healthy Longev"},{"key":"1697_CR5","doi-asserted-by":"publisher","unstructured":"The global, regional, and national burden attributable to low bone mineral density, 1990\u20132020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021. Lancet Rheumatol. 2025, https:\/\/doi.org\/10.1016\/s2665-9913(25)00105-5.10.1016\/s2665-9913(25)00105-5","DOI":"10.1016\/s2665-9913(25)00105-5.10.1016\/s2665-9913(25)00105-5"},{"key":"1697_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081250","volume":"390","author":"CWS Hoong","year":"2025","unstructured":"Hoong CWS, Saul D, Khosla S et al (2025) Advances in the management of osteoporosis. BMJ 390:e081250.10.1136\/bmj-2024-081250","journal-title":"BMJ"},{"key":"1697_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07661-4","author":"H Jin","year":"2025","unstructured":"Jin H, Jin H, Suk KS et al (2025) Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-025-07661-4","journal-title":"Osteoporos Int"},{"key":"1697_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41584-025-01287-w","volume":"21","author":"N Fuggle","year":"2025","unstructured":"Fuggle N, Rizzoli R, Beaudart C et al (2025) Parathyroid hormone receptor agonists in the management of osteoporosis. Nat Rev Rheumatol 21:599\u2013611. https:\/\/doi.org\/10.1038\/s41584-025-01287-w","journal-title":"Nat Rev Rheumatol"},{"key":"1697_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3803\/EnM.2025.2571","volume":"40","author":"KJ Kim","year":"2025","unstructured":"Kim KJ (2025) From bone health to lifespan: pleiotropic effects of antiresorptive agents. Endocrinol Metab 40:508\u2013516. https:\/\/doi.org\/10.3803\/EnM.2025.2571","journal-title":"Endocrinol Metab"},{"key":"1697_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2545417","volume":"17","author":"Y You","year":"2025","unstructured":"You Y, Xiang T, Yang C et al (2025) Interactions between the gut microbiota and immune cell dynamics: novel insights into the gut-bone axis. Gut Microbes 17:2545417. https:\/\/doi.org\/10.1080\/19490976.2025.2545417","journal-title":"Gut Microbes"},{"key":"1697_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1569152","volume":"16","author":"C Gu","year":"2025","unstructured":"Gu C, Du H, Li N et al (2025) The gut-bone axis in osteoporosis: a multifaceted interaction with implications for bone health. Front Endocrinol (Lausanne) 16:1569152. https:\/\/doi.org\/10.3389\/fendo.2025.1569152","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1697_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jbmr.4518","volume":"37","author":"ES Orwoll","year":"2022","unstructured":"Orwoll ES, Parimi N, Wiedrick J et al (2022) Analysis of the associations between the human fecal microbiome and bone density, structure, and strength: The osteoporotic fractures in men (MrOS) cohort. J Bone Miner Res 37:597\u2013607. https:\/\/doi.org\/10.1002\/jbmr.4518","journal-title":"J Bone Miner Res"},{"key":"1697_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/gerona\/glaa034","volume":"75","author":"M Shardell","year":"2020","unstructured":"Shardell M, Parimi N, Langsetmo L et al (2020) Comparing analytical methods for the gut microbiome and aging: Gut microbial communities and body weight in the osteoporotic fractures in men (MrOS) study. J Gerontol A Biol Sci Med Sci 75:1267\u201375. https:\/\/doi.org\/10.1093\/gerona\/glaa034","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1697_CR14","doi-asserted-by":"publisher","DOI":"10.7326\/annals-24-03547","volume":"178","author":"A Qaseem","year":"2025","unstructured":"Qaseem A, Cooney TG, Shamliyan TA et al (2025) Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians (Version 1: Update Alert 1: Surveillance Note 1). Ann Intern Med 178:e2403547. https:\/\/doi.org\/10.7326\/annals-24-03547","journal-title":"Ann Intern Med"},{"key":"1697_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169465","author":"A Aibar-Almaz\u00e1n","year":"2022","unstructured":"Aibar-Almaz\u00e1n A, Voltes-Mart\u00ednez A, Castellote-Caballero Y et al (2022) Current status of the diagnosis and management of osteoporosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23169465","journal-title":"Int J Mol Sci"},{"key":"1697_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00198-024-07025-4","volume":"35","author":"S Jeon","year":"2024","unstructured":"Jeon S, Yu D, Kim S et al (2024) Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture. Osteoporos Int 35:795\u2013804. https:\/\/doi.org\/10.1007\/s00198-024-07025-4","journal-title":"Osteoporos Int"},{"key":"1697_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60081314","author":"BT Kwon","year":"2024","unstructured":"Kwon BT, Ham DW, Park SM et al (2024) Impact of teriparatide and denosumab on clinical and radiographic outcomes in osteoporotic vertebral compression fractures. Medicina Kaunas. https:\/\/doi.org\/10.3390\/medicina60081314","journal-title":"Medicina Kaunas"},{"key":"1697_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/endrev\/bnac031","volume":"44","author":"M Schini","year":"2023","unstructured":"Schini M, Vilaca T, Gossiel F et al (2023) Bone turnover markers: basic biology to clinical applications. Endocr Rev 44:417\u201373. https:\/\/doi.org\/10.1210\/endrev\/bnac031","journal-title":"Endocr Rev"},{"issue":"1","key":"1697_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s40520-025-03239-6","volume":"37","author":"TK Paulin","year":"2025","unstructured":"Paulin TK, Malmgren L, Bartosch P et al (2025) Osteocalcin and frailty among older women. Aging Clin Exp Res 37:342. https:\/\/doi.org\/10.1007\/s40520-025-03239-6","journal-title":"Aging Clin Exp Res"},{"key":"1697_CR20","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1093\/ejendo\/lvae076","volume":"191","author":"AD Anastasilakis","year":"2024","unstructured":"Anastasilakis AD, Yavropoulou MP, Palermo A et al (2024) Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when? Eur J Endocrinol 191:R9-r21. https:\/\/doi.org\/10.1093\/ejendo\/lvae076","journal-title":"Eur J Endocrinol"},{"key":"1697_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s00198-023-06809-4","volume":"34","author":"N Kitcharanant","year":"2023","unstructured":"Kitcharanant N, Chattipakorn N, Chattipakorn SC (2023) The effect of intermittent parathyroid hormone on bone lengthening: current evidence to inform future effective interventions. Osteoporos Int 34:1657\u20131675. https:\/\/doi.org\/10.1007\/s00198-023-06809-4","journal-title":"Osteoporos Int"},{"key":"1697_CR22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jbmr\/zjaf118","volume":"40","author":"AL Bonnet","year":"2025","unstructured":"Bonnet AL, Aboishava L, Mannstadt M (2025) Advances in parathyroid hormone-based medicines. J Bone Miner Res 40:1195\u20131206. https:\/\/doi.org\/10.1093\/jbmr\/zjaf118","journal-title":"J Bone Miner Res"},{"key":"1697_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-024-00362-4","volume":"12","author":"BM El-Masri","year":"2024","unstructured":"El-Masri BM, Andreasen CM, Laursen KS et al (2024) Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. Bone Res 12:62. https:\/\/doi.org\/10.1038\/s41413-024-00362-4","journal-title":"Bone Res"},{"key":"1697_CR24","doi-asserted-by":"publisher","unstructured":"Liu C, Yang Y N, Guo S et al (2025) Gut microbiota-mediated regulation of skeletal development: a review of mechanistic analysis and interventional strategies. J Adv Res.\u00a0https:\/\/doi.org\/10.1016\/j.jare.2025.07.033.10.1016\/j.jare.2025.07.033","DOI":"10.1016\/j.jare.2025.07.033.10.1016\/j.jare.2025.07.033"},{"key":"1697_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1416739","volume":"14","author":"L Hao","year":"2024","unstructured":"Hao L, Yan Y, Huang G et al (2024) From gut to bone: deciphering the impact of gut microbiota on osteoporosis pathogenesis and management. Front Cell Infect Microbiol 14:1416739. https:\/\/doi.org\/10.3389\/fcimb.2024.1416739","journal-title":"Front Cell Infect Microbiol"},{"key":"1697_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/foods14162823","author":"Y Han","year":"2025","unstructured":"Han Y, Yang C, Tian X et al (2025) Grape Pomace Polyphenol Extract Alleviates Obesity in Mice and Improves Gut Microbiota and Short Chain Fatty Acids. Foods. https:\/\/doi.org\/10.3390\/foods14162823","journal-title":"Foods"},{"key":"1697_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156458","volume":"139","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wang M, Wang Z et al (2025) Polysaccharides from hawthorn fruit alleviate high-fat diet-induced NAFLD in mice by improving gut microbiota dysbiosis and hepatic metabolic disorder. Phytomedicine 139:156458. https:\/\/doi.org\/10.1016\/j.phymed.2025.156458","journal-title":"Phytomedicine"},{"key":"1697_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1013466","volume":"9","author":"ZR Huang","year":"2022","unstructured":"Huang ZR, Huang QZ, Chen KW et al (2022) Sanghuangporus vaninii fruit body polysaccharide alleviates hyperglycemia and hyperlipidemia via modulating intestinal microflora in type 2 diabetic mice. Front Nutr 9:1013466. https:\/\/doi.org\/10.3389\/fnut.2022.1013466","journal-title":"Front Nutr"},{"key":"1697_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu17060998","author":"Y Ding","year":"2025","unstructured":"Ding Y, Liu W, Zhang X et al (2025) Bicarbonate-rich mineral water mitigates hypoxia-induced osteoporosis in mice via gut microbiota and metabolic pathway regulation. Nutrients. https:\/\/doi.org\/10.3390\/nu17060998","journal-title":"Nutrients"},{"key":"1697_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112027","volume":"132","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Qian Y et al (2024) Ziyuglycoside II attenuated OVX mice bone loss via inflammatory responses and regulation of gut microbiota and SCFAs. Int Immunopharmacol 132:112027. https:\/\/doi.org\/10.1016\/j.intimp.2024.112027","journal-title":"Int Immunopharmacol"},{"key":"1697_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116943","volume":"283","author":"Y Ge","year":"2024","unstructured":"Ge Y, Jia Z, Zhao S et al (2024) Mitigating lead-induced osteoporosis: the role of butyrate in gut-bone axis restoration. Ecotoxicol Environ Saf 283:116943. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116943","journal-title":"Ecotoxicol Environ Saf"},{"key":"1697_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1493560","volume":"16","author":"Y Dong","year":"2025","unstructured":"Dong Y, Sun Y, Zhou Z et al (2025) Modulation of the gut-bone axis: Lacticaseibacillus paracasei LC86 improves bone health via anti-inflammatory metabolic pathways in zebrafish models of osteoporosis and cartilage damage. Front Immunol 16:1493560. https:\/\/doi.org\/10.3389\/fimmu.2025.1493560","journal-title":"Front Immunol"},{"key":"1697_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03751-x","volume":"23","author":"Z Li","year":"2025","unstructured":"Li Z, Deng X, Qiu C et al (2025) Orally administered degradable nanoarmor-assisted probiotics for remodeling the gut microenvironment and treating osteoporosis. J Nanobiotechnology 23:660. https:\/\/doi.org\/10.1186\/s12951-025-03751-x","journal-title":"J Nanobiotechnology"},{"key":"1697_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1302\/2046-3758.1011.Bjr-2021-0181.R1","volume":"10","author":"B Cheng","year":"2021","unstructured":"Cheng B, Wen Y, Yang X et al (2021) Gut microbiota is associated with bone mineral density\u202f: an observational and genome-wide environmental interaction analysis in the UK Biobank cohort. Bone Joint Res 10:734\u201341. https:\/\/doi.org\/10.1302\/2046-3758.1011.Bjr-2021-0181.R1","journal-title":"Bone Joint Res"},{"key":"1697_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ani14010162","author":"J Chang","year":"2024","unstructured":"Chang J, Jia X, Liu Y et al (2024) Microbial mechanistic insight into the role of yeast-derived postbiotics in improving sow reproductive performance in late gestation and lactation sows. Animals. https:\/\/doi.org\/10.3390\/ani14010162","journal-title":"Animals"},{"key":"1697_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-024-10267-7","author":"L Yang","year":"2024","unstructured":"Yang L, Wu Y, Zhao X et al (2024) An in vitro evaluation of the effect of Bifidobacterium longum L556 on microbiota composition and metabolic properties in patients with coronary heart disease (CHD). Probiotics and Antimicrobial Proteins. https:\/\/doi.org\/10.1007\/s12602-024-10267-7","journal-title":"Probiotics and Antimicrobial Proteins"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-026-01697-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-026-01697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:47:31Z","timestamp":1775645251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-026-01697-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1007\/s11657-026-01697-7","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Affiliated Gansu Provincial People\u2019s Hospital (Approval No. 2023-299).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"63"}}